Current literature has pointed that expression and release of PCSK9 depends on other chronic conditions including chronic kidney disease, hyperinsulinemia, hypothyroidism or non-alcoholic fatty liver disease (NAFLD) and also inflammation, which is a significant factor in psoriatic pathogenesis [24,25]. Here, PCSK9 is linked to hyperinsulinism.